共 119 条
[1]
Waxman S(2001)History of the development of arsenic derivatives in cancer therapy Oncologist 6 3-10
[2]
Anderson KC(2005)Effects of administration styles of arsenic trioxide on intracellular arsenic concentration, cell differentiation and apoptosis Haematologica 90 1277-1279
[3]
Zhou J(1997)Use of arsenic trioxide (As Blood 89 3354-3360
[4]
Meng R(2008)O Med Sci (Paris) 24 967-971
[5]
Sui XH(2000)) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 95 1014-1022
[6]
Shen ZX(1999)New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune disease Eur J Cancer 35 1258-1263
[7]
Chen GQ(2000)Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-xL Biochem Biophys Res Commun 277 179-185
[8]
Ni JH(2000)Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide Cancer Res 60 3065-3071
[9]
Bobe P(1997)Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 15 83-122
[10]
Chelbi-Alix MK(2002)Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis Regul Toxicol Pharmacol 36 162-174